Skip to search formSkip to main contentSkip to account menu

MAGE-12 peptide vaccine

Known as: MAGE-12 
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Objective To design and synthesis B-cell epitope of tumor antigen MAGE-12 and investigate its immunogenicity. Methods Based on… 
Highly Cited
2002
Highly Cited
2002
By stimulating human CD8+ T lymphocytes with autologous dendritic cells infected with an adenovirus encoding MAGE-3, we obtained… 
2002
Highly Cited
2001
Highly Cited
2001
The basis of intra‐tumoral and systemic T cell reactivity toward cancer remains unclear. In particular the role that peripheral… 
Highly Cited
2000
Highly Cited
2000
Twenty separate tumor infiltrating lymphocyte (TIL) bulk cultures and a tumor cell line were originated simultaneously from a… 
2000
2000
&NA; MAGE proteins have been identified as potential specific targets for cancer vaccination. Although MAGE‐6 and MAGE‐12 were… 
2000
2000
MAGE proteins have been identified as potential specific targets for cancer vaccination. Although MAGE-6 and MAGE-12 were… 
1999
1999
Purpose: The possibility of tumor rejection antigen, encoded by the MAGE-1 gene, being a target for immunotherapy in… 
1996
1996
Melanoma-associated genes (MAGEs) encode tumor-specific antigens that can be recognized by CD8 cytotoxic T lymphocytes. To… 
1994
1994
The spectrum of MAGE gene expression in the human melanoma cell line DM150 was examined using reverse transcription polymerase…